Last updated: 22 August 2018 at 7:55am EST

Gp Iii, Llclatterell Patric... Net Worth




The estimated Net Worth of Gp Iii, Llclatterell Patric... is at least $195 ezer dollars as of 20 August 2018. Gp Patric owns over 500,000 units of Evoke Pharma Inc stock worth over $194,770 and over the last 6 years Gp sold EVOK stock worth over $0.

Gp Patric EVOK stock SEC Form 4 insiders trading

Gp has made over 1 trades of the Evoke Pharma Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Gp bought 500,000 units of EVOK stock worth $1,175,000 on 20 August 2018.

The largest trade Gp's ever made was buying 500,000 units of Evoke Pharma Inc stock on 20 August 2018 worth over $1,175,000. On average, Gp trades about 500,000 units every 0 days since 2018. As of 20 August 2018 Gp still owns at least 48,449 units of Evoke Pharma Inc stock.

You can see the complete history of Gp Patric stock trades at the bottom of the page.



What's Gp Patric's mailing address?

Gp's mailing address filed with the SEC is Bishop Ranch 3, 2603 Camino Ramon, San Ramon, CA 94583, United States.

Insiders trading at Evoke Pharma Inc

Over the last 11 years, insiders at Evoke Pharma Inc have traded over $3,263,070 worth of Evoke Pharma Inc stock and bought 954,000 units worth $2,502,800 . The most active insiders traders include Nicole Vitullo, Jesse I Treu és Brian K Halak. On average, Evoke Pharma Inc executives and independent directors trade stock every 100 days with the average trade being worth of $308,145. The most recent stock trade was executed by David A Gonyer on 11 December 2020, trading 72,000 units of EVOK stock currently worth $209,520.



What does Evoke Pharma Inc do?

evoke pharma is a biotechnology company located in 505 lomas santa fe dr, solana beach, california, united states.



Complete history of Gp Patric stock trades at Evoke Pharma Inc

Az érdekelt
Trans.
Tranzakció
Teljes ár
Gp Iii, Llclatterell Patric...
Megvenni $1,175,000
20 Aug 2018


Evoke Pharma Inc executives and stock owners

Evoke Pharma Inc executives and other stock owners filed with the SEC include: